422 related articles for article (PubMed ID: 16496404)
41. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.
Nomura A; Stemmermann GN; Chyou PH; Kato I; Perez-Perez GI; Blaser MJ
N Engl J Med; 1991 Oct; 325(16):1132-6. PubMed ID: 1891021
[TBL] [Abstract][Full Text] [Related]
42. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma.
Parsonnet J; Samloff IM; Nelson LM; Orentreich N; Vogelman JH; Friedman GD
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):461-6. PubMed ID: 8220091
[TBL] [Abstract][Full Text] [Related]
43. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China.
Limburg P; Qiao Y; Mark S; Wang G; Perez-Perez G; Blaser M; Wu Y; Zou X; Dong Z; Taylor P; Dawsey S
J Natl Cancer Inst; 2001 Feb; 93(3):226-33. PubMed ID: 11158192
[TBL] [Abstract][Full Text] [Related]
44. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan.
Lin JT; Wang LY; Wang JT; Wang TH; Yang CS; Chen CJ
Anticancer Res; 1995; 15(2):603-6. PubMed ID: 7763044
[TBL] [Abstract][Full Text] [Related]
45. Low seroprevalence of Helicobacter pylori antibodies in historical sera of patients with Crohn's disease.
Wagtmans MJ; Witte AM; Taylor DR; Biemond I; Veenendaal RA; Verspaget HW; Lamers CB; van Hogezand RA
Scand J Gastroenterol; 1997 Jul; 32(7):712-8. PubMed ID: 9246713
[TBL] [Abstract][Full Text] [Related]
46. Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study.
Ikeda F; Shikata K; Hata J; Fukuhara M; Hirakawa Y; Ohara T; Mukai N; Nagata M; Yoshida D; Yonemoto K; Esaki M; Kitazono T; Kiyohara Y; Ninomiya T
J Epidemiol; 2016 Dec; 26(12):629-636. PubMed ID: 27265836
[TBL] [Abstract][Full Text] [Related]
47. Association of CagA-positive infection with Helicobacter pylori antibodies of IgA class.
Rautelin HI; Oksanen AM; Karttunen RA; Seppälä KM; Virtamo JR; Aromaa AJ; Kosunen TU
Ann Med; 2000 Dec; 32(9):652-6. PubMed ID: 11209973
[TBL] [Abstract][Full Text] [Related]
48. Risk for gastric cancer after antibiotic prophylaxis in patients undergoing hip replacement.
Akre K; Signorello LB; Engstrand L; Bergström R; Larsson S; Eriksson BI; Nyrén O
Cancer Res; 2000 Nov; 60(22):6376-80. PubMed ID: 11103800
[TBL] [Abstract][Full Text] [Related]
49. Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negative.
Jonkers D; Houben P; Hameeteman W; Stobberingh E; de Bruine A; Arends JW; Biemond I; Lundqvist G; Stockbrügger R
Ital J Gastroenterol Hepatol; 1999 Dec; 31(9):836-41. PubMed ID: 10669990
[TBL] [Abstract][Full Text] [Related]
50. Frequency of Helicobacter pylori -negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy.
Ono S; Kato M; Suzuki M; Ishigaki S; Takahashi M; Haneda M; Mabe K; Shimizu Y
Digestion; 2012; 86(1):59-65. PubMed ID: 22722747
[TBL] [Abstract][Full Text] [Related]
51. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
[TBL] [Abstract][Full Text] [Related]
52. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
53. Tissue IgA antibody against Helicobacter pylori in patients with gastroduodenal diseases: comparison with bacterial culture, serum IgG antibody, and [13C]Urea breath test.
Matsukura N; Onda M; Tokunaga A; Kato S; Kyono S; Yamashita K
J Clin Gastroenterol; 1995; 21 Suppl 1():S146-50. PubMed ID: 8775008
[TBL] [Abstract][Full Text] [Related]
54. Comparison of serum IgA and IgG antibodies for detecting Helicobacter pylori infection.
Urita Y; Hike K; Torii N; Kikuchi Y; Kurakata H; Kanda E; Sasajima M; Miki K
Intern Med; 2004 Jul; 43(7):548-52. PubMed ID: 15335178
[TBL] [Abstract][Full Text] [Related]
55. Association of Helicobacter pylori IgA antibodies with the risk of peptic ulcer disease and gastric cancer.
Kosunen TU; Seppala K; Sarna S; Aromaa A; Knekt P; Virtamo J; Salomaa-Rasanen A; Rautelin H
World J Gastroenterol; 2005 Nov; 11(43):6871-4. PubMed ID: 16425400
[TBL] [Abstract][Full Text] [Related]
56. Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H. pylori infection in patients with precancerous lesions.
Li S; Lu AP; Zhang L; Li YD
World J Gastroenterol; 2003 Apr; 9(4):755-8. PubMed ID: 12679926
[TBL] [Abstract][Full Text] [Related]
57. Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community.
Zhang X; Xue L; Xing L; Wang J; Cui J; Mi J; Xing X; Wang J; Du Z; Misumi J; Tian Q; Wang L
Int J Cancer; 2012 Apr; 130(7):1614-9. PubMed ID: 21547904
[TBL] [Abstract][Full Text] [Related]
58. Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests.
Hamashima C; Sasazuki S; Inoue M; Tsugane S;
BMC Cancer; 2017 Mar; 17(1):183. PubMed ID: 28279154
[TBL] [Abstract][Full Text] [Related]
59. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori.
Suzuki G; Cullings H; Fujiwara S; Hattori N; Matsuura S; Hakoda M; Akahoshi M; Kodama K; Tahara E
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1224-8. PubMed ID: 17548689
[TBL] [Abstract][Full Text] [Related]
60. Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study.
Kiso M; Yoshihara M; Ito M; Inoue K; Kato K; Nakajima S; Mabe K; Kobayashi M; Uemura N; Yada T; Oka M; Kawai T; Boda T; Kotachi T; Masuda K; Tanaka S; Chayama K
Gastric Cancer; 2017 Sep; 20(5):764-771. PubMed ID: 28025702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
